• 20 Jan 2017

    Nemus Bioscience Announces Licensing Agreement with the University of Mississippi

    COSTA MESA, CA / ACCESSWIRE / January 11, 2017 / NEMUS Bioscience, Inc. (OTCQB: NMUS) announced that the company had signed a licensing agreement with the University of Mississippi (UM) for a platform of cannabinoid-based molecules (UM5070) for potential anti-infective use against bacteria, viruses, and fungi. The agreement culminates roughly one year of screening and target molecule identification studies especially focused on therapy-resistant infectious organisms like methicillin-resistant Staphylococcus aureus (MRSA).   Read more →